Anthony H Nguyen

Array ( [id] => 162586 [patent_doc_number] => 07671036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Positively-charged peptide nucleic acid analogs with improved properties' [patent_app_type] => utility [patent_app_number] => 10/297788 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10200 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671036.pdf [firstpage_image] =>[orig_patent_app_number] => 10297788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1088992 [patent_doc_number] => 06828148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Miniribozymes active at low magnesium ion concentrations' [patent_app_type] => B2 [patent_app_number] => 09/887880 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 21105 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 312 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828148.pdf [firstpage_image] =>[orig_patent_app_number] => 09887880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818452 [patent_doc_number] => 20030069410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Methods for preparing oligonucleotides having chiral phosphorothioate linkages' [patent_app_type] => new [patent_app_number] => 09/881535 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16942 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069410.pdf [firstpage_image] =>[orig_patent_app_number] => 09881535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6647958 [patent_doc_number] => 20030104520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Regulatable, catalytically active nucleic acids' [patent_app_type] => new [patent_app_number] => 09/883119 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 28375 [patent_no_of_claims] => 136 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104520.pdf [firstpage_image] =>[orig_patent_app_number] => 09883119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525841 [patent_doc_number] => 20020192651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method of preventing aggregation of a lipid: nucleic acid complex' [patent_app_type] => new [patent_app_number] => 09/875805 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 28638 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192651.pdf [firstpage_image] =>[orig_patent_app_number] => 09875805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159546 [patent_doc_number] => 20020147324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'RPS gene family, primers, probes, and detection methods' [patent_app_type] => new [patent_app_number] => 09/867852 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18484 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147324.pdf [firstpage_image] =>[orig_patent_app_number] => 09867852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500093 [patent_doc_number] => 06485974 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Antisense modulation of PTPN2 expression' [patent_app_type] => B1 [patent_app_number] => 09/861159 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27039 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485974.pdf [firstpage_image] =>[orig_patent_app_number] => 09861159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405323 [patent_doc_number] => 20020037554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Isolated and purified 12R-lipoxygenase polypeptide and polynucleic acid encoding the same' [patent_app_type] => new [patent_app_number] => 09/853053 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21792 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037554.pdf [firstpage_image] =>[orig_patent_app_number] => 09853053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797500 [patent_doc_number] => 20030176374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Oligonucleotide compositions and methods for the modulation of the expression of B7 protein' [patent_app_type] => new [patent_app_number] => 09/851871 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 32023 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176374.pdf [firstpage_image] =>[orig_patent_app_number] => 09851871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473564 [patent_doc_number] => 20020151511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Antisense oligonucleotide modulation of human MDM2 expression' [patent_app_type] => new [patent_app_number] => 09/851771 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9967 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151511.pdf [firstpage_image] =>[orig_patent_app_number] => 09851771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947873 [patent_doc_number] => 20010021507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use' [patent_app_type] => new [patent_app_number] => 09/850128 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7794 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021507.pdf [firstpage_image] =>[orig_patent_app_number] => 09850128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693181 [patent_doc_number] => 20030040613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Structurally modified molecular decoys for the manipulation of cellular or viral replication and other uses relating thereto' [patent_app_type] => new [patent_app_number] => 09/841236 [patent_app_country] => US [patent_app_date] => 2001-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4253 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040613.pdf [firstpage_image] =>[orig_patent_app_number] => 09841236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843590 [patent_doc_number] => 20030148937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Methods and compositions for use in spliceosome mediated RNA trans-splicing' [patent_app_type] => new [patent_app_number] => 09/838858 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 26462 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148937.pdf [firstpage_image] =>[orig_patent_app_number] => 09838858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617882 [patent_doc_number] => 20020085998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer' [patent_app_type] => new [patent_app_number] => 09/834759 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48130 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20020085998.pdf [firstpage_image] =>[orig_patent_app_number] => 09834759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985170 [patent_doc_number] => 20020098231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Oligonucleotide inhibitors of bcl-xL' [patent_app_type] => new [patent_app_number] => 09/832648 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5649 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098231.pdf [firstpage_image] =>[orig_patent_app_number] => 09832648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065741 [patent_doc_number] => 20010044528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Chimeric antisense oligonucleotides and cell transfecting formulations thereof' [patent_app_type] => new [patent_app_number] => 09/826519 [patent_app_country] => US [patent_app_date] => 2001-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5243 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044528.pdf [firstpage_image] =>[orig_patent_app_number] => 09826519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711113 [patent_doc_number] => 20030170862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Nuclear factor kappaB inducing factor' [patent_app_type] => new [patent_app_number] => 09/823119 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21344 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170862.pdf [firstpage_image] =>[orig_patent_app_number] => 09823119 [rel_patent_id] =>[rel_patent_doc_number] =>)